KIF21B and Alzheimer disease: In AD, high kif21b expression was associated with a significantly shorter disease duration (Spearman’s rho -0.36, p = 0.02, Figure 8A) and a similar trend was observed in MS (Spearman’s rho -0.27, p = 0.067, Figure 8B).